Switzerland clears Pfizer/BioNTech vaccine for 12 to 15-year-olds
Adolescents have the same protection and side effects from the Pfizer/Biontech vaccine as 25-year-olds, studies have shown.
Keystone / Martial Trezzini
The Swiss health regulator Swissmedic has approved the use of the Pfizer/BioNTech vaccine for children aged as young as 12.
This content was published on
1 minute
swissinfo.ch/mga
Tests have shown the vaccine to be close to 100% effective at giving protection against Covid-19 for 12 to 15-year-olds, the agency said on FridayExternal link.
Children in this age group can be given two injections with the same dose as adults, resulting in the same immune response as 16- to 25-year-olds, trials have shown.
The range and severity of side effects proved to be no different between the two age groups: most frequently pain at the injection site, fatigue, headache, shivering, muscle pain, fever and joint pain lasting typically around three days and more pronounced after the second injection.
Last month, regulators in the United States approved the use of the Pfizer/BioNTech vaccine for children as young as 12.
The vaccine roll-out is accelerating in Switzerland. More than five million vaccination doses (Pfizer/BioNTech and Moderna) have been administered so far. Just over 22% of the population has been fully immunised, with another 15.4% having received one jab.
On Friday, the number of new recorded daily infections fell below 500 for the first time since the autumn.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
This content was published on
The Ethos Foundation recommends that shareholders vote against all compensation-related items at the Annual General Meeting on March 7.
Top Swiss firms close to reaching gender quota in boards
This content was published on
The proportion of women on the boards of directors of the fifty largest listed companies in Switzerland currently stands at 28%.
Swiss committee wants to end government resignations during legislative term
This content was published on
Members of the Federal Council should no longer be able to leave office before the end of their term, according to a House of Representatives committee.
Swiss government seat: Ritter and Pfister nominated to succeed Amherd
This content was published on
Markus Ritter from St Gallen and Martin Pfister from Zug were officially nominated by the Centre Party on Friday to succeed Defence Minister Viola Amherd.
Top Swiss court rejects Russian request for administrative tax assistance
This content was published on
There is currently no reason to transmit banking information to the Russian Federation, the Swiss Federal Court has ruled.
After strike by radiologists, doctors demonstrate in Bern
This content was published on
Following a strike by radiology technicians in Fribourg, doctors, vets, dentists and chiropractors expressed their frustration on Friday outside parliament in the Swiss capital.
This content was published on
At the start of the year, the Swiss authorities were criticised for dragging their heels on vaccinations despite having ambitious targets. Drugs regulator Swissmedic took longer than many countries to approve new vaccines and when they arrived there were large discrepancies between the ability of cantons to administer doses at speed. But this week, Switzerland…
Covid-19: ‘No one will be safe until everyone is safe’
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has launched a new appeal to help those most in need.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.